Avian Necrotic Enteritis in Poultry: Pathogenesis and Management

Introduction

Avian necrotic enteritis (NE) is an economically significant enteric disease of poultry, primarily affecting broiler chickens. The disease is characterized by acute necrosis of the intestinal mucosa, leading to decreased performance, mortality, and increased condemnation rates at processing. The primary etiological agent is Clostridium perfringens, a Gram-positive, spore-forming, anaerobic bacillus. While C. perfringens is a ubiquitous component of the normal intestinal microbiota of poultry, specific predisposing factors are required to trigger clinical disease. This article provides a detailed review of the etiology, epidemiology, pathogenesis, clinical signs, pathology, diagnostics, treatment, and control of avian necrotic enteritis, with a focus on the mechanisms underlying chicken necrosis of the intestinal epithelium.

Etiology

Clostridium perfringens is the causative agent of necrotic enteritis. The bacterium is classified into five toxinotypes (A, B, C, D, E) based on the production of four major toxins (alpha, beta, epsilon, iota). In poultry, NE is predominantly associated with C. perfringens type A and, less frequently, type C. The primary virulence factor in type A strains is the alpha-toxin (CPA), a phospholipase C enzyme that hydrolyzes phosphatidylcholine and sphingomyelin in host cell membranes. This activity disrupts membrane integrity, leading to cell lysis and necrosis. A second critical virulence factor, NetB (necrotic enteritis B-like toxin), is a pore-forming toxin that is strongly associated with the pathogenesis of NE in broilers. NetB is produced by virulent strains of C. perfringens and is considered essential for the development of clinical disease. The bacterium also produces a range of other extracellular enzymes, including collagenase, hyaluronidase, and proteases, which facilitate tissue invasion and nutrient acquisition.

Epidemiology

Necrotic enteritis is a disease of global distribution, with prevalence varying by management system, geographic region, and the use of antimicrobial growth promoters (AGPs). The disease is most commonly observed in broiler chickens aged 2 to 6 weeks, with peak incidence typically occurring between 3 and 4 weeks of age. The disease is less common in layers and breeders, although sporadic outbreaks can occur. The primary source of C. perfringens is the environment, including litter, feed, and water. The bacterium is highly resilient due to its ability to form spores, which can persist in the environment for extended periods. Transmission is primarily fecal-oral, with birds ingesting spores or vegetative cells from contaminated litter or feed. The disease is often multifactorial, with several predisposing factors that disrupt the intestinal ecosystem and create a permissive environment for C. perfringens overgrowth. These factors include dietary changes (e.g., high-protein diets, wheat-based rations), coccidial infection (particularly Eimeria spp.), immunosuppression, and stress.

Pathogenesis

The pathogenesis of NE is a complex, multifactorial process that involves the interplay between the host, the pathogen, and the intestinal microenvironment. The disease process can be divided into several stages.

Predisposing Factors and Intestinal Dysbiosis

Under normal conditions, C. perfringens is present in the ceca and lower intestine at low levels, typically less than 10^4 colony-forming units (CFU) per gram of intestinal content. Clinical disease requires a significant increase in the intestinal population of toxigenic C. perfringens, often exceeding 10^7 to 10^8 CFU per gram. This overgrowth is facilitated by factors that alter the intestinal microbiota and provide a nutrient-rich environment for the bacterium. Dietary factors, such as high levels of non-starch polysaccharides (NSPs) from wheat, barley, or rye, increase the viscosity of intestinal digesta, slowing transit time and promoting bacterial proliferation. High-protein diets, particularly those containing animal-derived proteins (e.g., fishmeal), provide a rich source of amino acids and peptides that favor C. perfringens growth. Concurrent infection with coccidia, especially Eimeria acervulina, Eimeria maxima, or Eimeria necatrix, is a well-established predisposing factor. Coccidial infection causes mucosal damage, providing a source of serum proteins and tissue debris that serve as substrates for C. perfringens. Furthermore, coccidial infection induces a local inflammatory response that alters the intestinal microenvironment and may compromise the integrity of the epithelial barrier.

Toxin-Mediated Mucosal Necrosis

Once C. perfringens reaches a critical population density, it produces its key virulence factors. Alpha-toxin (CPA) is a zinc-dependent phospholipase C that cleaves phosphatidylcholine and sphingomyelin, two major components of eukaryotic cell membranes. This enzymatic activity leads to membrane disruption, cell lysis, and the release of cellular contents, which further fuels bacterial growth. NetB is a beta-pore-forming toxin that oligomerizes to form heptameric pores in the plasma membrane of host cells, leading to osmotic lysis and cell death. The combined action of CPA and NetB results in extensive necrosis of the intestinal villi, particularly in the jejunum and ileum. The necrotic lesions are characterized by a thick, pseudomembranous layer composed of fibrin, necrotic epithelial cells, and inflammatory cells. The loss of the epithelial barrier allows for the translocation of bacteria and bacterial toxins into the portal circulation, potentially leading to systemic toxemia and death. The specific mechanisms of chicken necrosis at the cellular level involve the activation of intracellular signaling pathways, including the mitogen-activated protein kinase (MAPK) pathway and the inflammasome, which amplify the inflammatory response and contribute to tissue damage.

Clinical Signs

The clinical presentation of NE can be acute, subacute, or chronic. In the acute form, mortality can rise rapidly, often without premonitory signs. Affected birds may be found dead in good body condition. In subacute cases, birds exhibit depression, anorexia, ruffled feathers, diarrhea (often dark or bloody), and a reluctance to move. Morbidity and mortality rates vary widely, typically ranging from 5% to 50% in untreated flocks. Chronic NE is characterized by poor growth, uneven flock uniformity, and mild, persistent diarrhea. Subclinical NE, which is more common than the clinical form, results in reduced feed conversion efficiency and weight gain without overt signs of disease. This subclinical form is a significant contributor to economic losses in the broiler industry.

Pathology

Gross pathological findings are primarily confined to the small intestine, particularly the jejunum and ileum. The intestinal wall is typically distended, friable, and congested. The mucosal surface is covered by a characteristic "Turkish towel" or "carpet-like" pseudomembrane composed of fibrin, necrotic debris, and inflammatory cells. The intestinal lumen may contain a dark, bloody fluid. In severe cases, the necrosis can extend into the deeper layers of the intestinal wall, leading to perforation and secondary peritonitis. The liver may be enlarged, pale, and friable, and the gallbladder is often distended. Microscopic examination reveals extensive coagulative necrosis of the villi, with loss of the epithelial lining and the presence of large Gram-positive rods within the necrotic debris. A mixed inflammatory infiltrate, consisting of heterophils, macrophages, and lymphocytes, is present in the lamina propria and submucosa. Fibrin thrombi may be observed in the submucosal blood vessels.

Diagnosis

A definitive diagnosis of NE is based on a combination of clinical signs, gross pathology, histopathology, and microbiological isolation.

Clinical and Pathological Assessment

A presumptive diagnosis can be made based on the characteristic gross lesions observed at necropsy. The presence of the pseudomembrane in the small intestine, along with a history of acute mortality and predisposing factors, is highly suggestive of NE.

Histopathology

Histological examination of affected intestinal tissue confirms the diagnosis. The presence of coagulative necrosis, fibrin deposition, and large Gram-positive rods is pathognomonic.

Microbiological Isolation and Identification

C. perfringens can be isolated from intestinal contents or liver samples using anaerobic culture on selective media, such as tryptose-sulfite-cycloserine (TSC) agar or neomycin blood agar. Colonies are typically gray, circular, and surrounded by a zone of double hemolysis on blood agar. Confirmation of the species is achieved through Gram staining, biochemical tests (e.g., lecithinase production, lactose fermentation), and the detection of specific toxins. Molecular methods, including polymerase chain reaction (PCR) assays targeting the cpa and netB genes, are used to confirm the presence of toxigenic strains and to differentiate between type A and type C isolates. Quantitative PCR (qPCR) can be used to quantify C. perfringens in intestinal samples, providing a measure of bacterial load.

Differential Diagnosis

The differential diagnosis for NE includes other causes of enteritis in poultry, such as coccidiosis, ulcerative enteritis (caused by Clostridium colinum), salmonellosis, and viral enteritides (e.g., avian reovirus, rotavirus). A detailed discussion of these conditions can be found in the article on Necrotic Enteritis in Poultry: Etiology, Pathogenesis, Diagnosis, and Control. Coccidiosis can be differentiated by the presence of oocysts in fecal smears or intestinal scrapings and by the characteristic gross lesions (e.g., petechiae, mucosal thickening). Ulcerative enteritis is distinguished by the presence of discrete, button-like ulcers in the intestine and liver, and the causative agent, C. colinum, can be isolated on selective media. A comprehensive diagnostic approach is essential for accurate diagnosis and appropriate management.

Treatment

The treatment of clinical NE is primarily based on the administration of antimicrobial agents effective against C. perfringens. Historically, a range of antibiotics, including bacitracin, penicillin, lincomycin, and tetracyclines, have been used with variable success. However, the emergence of antimicrobial resistance (AMR) and increasing regulatory restrictions on the use of antibiotics in food-producing animals have limited therapeutic options. The choice of antimicrobial should be guided by in vitro susceptibility testing, where possible. Water-soluble antibiotics are often preferred for rapid administration to large flocks. Supportive care, including the provision of clean water, high-quality feed, and optimal environmental conditions, is critical for recovery. The use of probiotics, prebiotics, and organic acids as adjunct therapies has been explored, but their efficacy in treating acute clinical disease is limited. For a broader perspective on antimicrobial strategies, refer to the article on Poultry Bacteria Infections: Comprehensive Overview of Pathogenesis, Diagnosis, and Antimicrobial Strategies.

Control and Prevention

The control of NE requires a multifaceted approach that addresses the predisposing factors and reduces the intestinal load of C. perfringens.

Management and Biosecurity

Good management practices are the cornerstone of NE prevention. These include maintaining clean, dry litter, optimizing ventilation, and minimizing stress. Strict biosecurity protocols should be implemented to prevent the introduction of C. perfringens spores into the flock. All-in/all-out production systems, with thorough cleaning and disinfection between flocks, are essential for breaking the cycle of infection.

Nutritional Strategies

Dietary manipulation is a key component of NE control. The use of low-viscosity grains (e.g., corn) instead of high-NSP grains (e.g., wheat, barley) can reduce intestinal viscosity and limit bacterial proliferation. The inclusion of exogenous enzymes (e.g., xylanases, beta-glucanases) in wheat- or barley-based diets can degrade NSPs and reduce digesta viscosity. The use of organic acids (e.g., formic acid, propionic acid) in feed or water can lower the pH of the intestinal contents and inhibit the growth of C. perfringens. The addition of probiotics (e.g., Lactobacillus spp., Bacillus spp.) and prebiotics (e.g., mannan-oligosaccharides, fructo-oligosaccharides) can promote a healthy intestinal microbiota and competitively exclude pathogenic bacteria. Detailed information on these approaches is available in the article on Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies.

Coccidiosis Control

Effective control of coccidiosis is critical for preventing NE. This can be achieved through the use of anticoccidial drugs (ionophores or chemicals) in feed, or through vaccination with live attenuated or non-attenuated coccidial vaccines. A strategic rotation of anticoccidial products is recommended to prevent the development of resistance.

Vaccination

The development of effective vaccines against NE has been a major research focus. Both inactivated (bacterin) and toxoid vaccines, targeting CPA and NetB, have been developed. Maternal antibodies, transferred via the yolk, can provide passive protection to chicks during the first few weeks of life. Active immunization of breeders with these vaccines can confer passive immunity to progeny. However, the efficacy of these vaccines under field conditions has been variable, and further research is needed to optimize vaccine formulations and delivery strategies.

Antimicrobial Alternatives

Given the global push to reduce antibiotic use in poultry production, there is intense interest in developing non-antibiotic alternatives for NE control. These include the use of bacteriophages, bacteriocins (e.g., nisin), plant-derived compounds (e.g., essential oils, tannins), and immune modulators. While many of these alternatives have shown promise in experimental settings, their consistent efficacy under commercial conditions remains to be fully demonstrated. The article on Clostridium perfringens Type A in Broilers: Necrotic Enteritis Diagnosis and Alternatives to Antibiotics provides a detailed overview of these strategies.

Conclusion

Avian necrotic enteritis remains a major challenge for the global poultry industry. The disease is caused by toxigenic strains of C. perfringens, with CPA and NetB being the primary virulence factors. The pathogenesis is multifactorial, requiring a convergence of predisposing factors that disrupt the intestinal ecosystem and permit bacterial overgrowth. Effective control relies on an integrated approach that combines good management practices, nutritional optimization, coccidiosis control, and, where appropriate, vaccination. The development of effective, sustainable, non-antibiotic alternatives is a critical priority for the future of poultry health and production.

References

1. Cooper, K. K., & Songer, J. G. (2009). Necrotic enteritis in chickens: a paradigm of enteric infection by Clostridium perfringens type A. Anaerobe, 15(1-2), 55-60.
2. Keyburn, A. L., Boyce, J. D., Vaz, P., Bannam, T. L., Ford, M. E., Parker, D., ... & Moore, R. J. (2008). NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathogens, 4(2), e26.
3. Timbermont, L., Haesebrouck, F., Ducatelle, R., & Van Immerseel, F. (2011). Necrotic enteritis in broilers: an updated review on the pathogenesis. Avian Pathology, 40(4), 341-347.
4. Van Immerseel, F., De Buck, J., Pasmans, F., Huyghebaert, G., Haesebrouck, F., & Ducatelle, R. (2004). Clostridium perfringens in poultry: an emerging threat for animal and public health. Avian Pathology, 33(6), 537-549.
5. McDevitt, R. M., Brooker, J. D., Acamovic, T., & Sparks, N. H. C. (2006). Necrotic enteritis; a continuing challenge for the poultry industry. World's Poultry Science Journal, 62(2), 221-247.
6. Dahiya, J. P., Wilkie, D. C., Van Kessel, A. G., & Drew, M. D. (2006). Potential strategies for controlling necrotic enteritis in broiler chickens in post-antibiotic era. Animal Feed Science and Technology, 129(1-2), 60-88.
7. Gholamiandehkordi, A. R., Timbermont, L., Lanckriet, A., Van Den Broeck, W., Pedersen, K., Dewulf, J., ... & Van Immerseel, F. (2007). Quantification of gut lesions in a subclinical necrotic enteritis model. Avian Pathology, 36(5), 375-382.
8. Williams, R. B. (2005). Intercurrent coccidiosis and necrotic enteritis of chickens: rational, integrated disease management by maintenance of gut integrity. Avian Pathology, 34(3), 159-180.
9. Prescott, J. F., & Gyles, C. L. (1993). Clostridium perfringens in animal disease: a review of current knowledge. Canadian Veterinary Journal, 34(10), 611-617.
10. Rood, J. I., & Cole, S. T. (1991). Molecular genetics and pathogenesis of Clostridium perfringens. Microbiological Reviews, 55(4), 621-648.
11. Songer, J. G. (1996). Clostridial enteric diseases of domestic animals. Clinical Microbiology Reviews, 9(2), 216-234.
12. Lovland, A., & Kaldhusdal, M. (2001). Severely impaired production performance in broiler flocks with high incidence of Clostridium perfringens-associated hepatitis. Avian Pathology, 30(1), 73-81.
13. Kaldhusdal, M., & Hofshagen, M. (1992). Barley inclusion and avoparcin supplementation in broiler diets. 2. Clinical, pathological, and bacteriological findings in a mild form of necrotic enteritis. Poultry Science, 71(7), 1145-1153.
14. Craven, S. E. (2000). Colonization of the intestinal tract of broiler chicks by Clostridium perfringens. Avian Diseases, 44(4), 893-899.
15. Si, W., Gong, J., Han, Y., Yu, H., Brennan, J., Zhou, H., & Chen, S. (2007). Quantification of cell proliferation and alpha-toxin gene expression of Clostridium perfringens in the developing chicken gut by real-time PCR. Applied and Environmental Microbiology, 73(1), 196-201.
16. Collier, C. T., van der Klis, J. D., Deplancke, B., Anderson, D. B., & Gaskins, H. R. (2003). Effects of tylosin on bacterial mucolysis, Clostridium perfringens colonization, and intestinal barrier function in a chick model of necrotic enteritis. Antimicrobial Agents and Chemotherapy, 47(10), 3311-3317.
17. Hofshagen, M., & Kaldhusdal, M. (1992). Barley inclusion and avoparcin supplementation in broiler diets. 1. Effect on small intestinal bacterial flora and performance. Poultry Science, 71(6), 959-969.
18. Branton, S. L., Lott, B. D., Deaton, J. W., Maslin, W. R., & Austin, F. W. (1997). The effect of added complex carbohydrates or added dietary fiber on necrotic enteritis lesions in broiler chickens. Poultry Science, 76(1), 24-28.
19. Jackson, M. E., Fodge, D. W., & Hsiao, H. Y. (1999). Effects of beta-mannanase in corn-soybean meal diets on laying hen performance. Poultry Science, 78(12), 1737-1741.
20. Engberg, R. M., Hedemann, M. S., Leser, T. D., & Jensen, B. B. (2000). Effect of zinc bacitracin and salinomycin on intestinal microflora and performance of broilers. Poultry Science, 79(9), 1311-1319.
21. Knarreborg, A., Simon, M. A., Engberg, R. M., Jensen, B. B., & Tannock, G. W. (2002). Effects of dietary fat source and subtherapeutic levels of antibiotic on the bacterial community in the ileum of broiler chickens at various ages. Applied and Environmental Microbiology, 68(12), 5918-5924.
22. Wise, M. G., & Siragusa, G. R. (2007). Quantitative analysis of the intestinal bacterial community in one- to three-week-old commercially reared broiler chickens fed conventional or antibiotic-free diets. Applied and Environmental Microbiology, 73(5), 1478-1485.
23. Torok, V. A., Ophel-Keller, K., Loo, M., & Hughes, R. J. (2008). Application of methods for identifying broiler chicken gut bacterial species linked with increased energy metabolism. Applied and Environmental Microbiology, 74(24), 7831-7839.
24. Stanley, D., Hughes, R. J., & Moore, R. J. (2014). Microbiota of the chicken gastrointestinal tract: influence on health, productivity and disease. Applied Microbiology and Biotechnology, 98(10), 4301-4310.
25. Caly, D. L., D'Inca, R., Auclair, E., & Drider, D. (2015). Alternatives to antibiotics to prevent necrotic enteritis in broiler chickens: a microbiologist's perspective. Frontiers in Microbiology, 6, 1336.
26. M'Sadeq, S. A., Wu, S., Swick, R. A., & Choct, M. (2015). Towards the control of necrotic enteritis in broiler chickens with in-feed antibiotics phasing-out worldwide. Animal Nutrition, 1(1), 1-11.
27. Lee, K. W., Lillehoj, H. S., & Siragusa, G. R. (2010). Direct-fed microbials and their impact on the intestinal microflora and immune system of chickens. Journal of Poultry Science, 47(2), 106-114.
28. Allaart, J. G., van Asten, A. J., & Grone, A. (2013). Predisposing factors and prevention of Clostridium perfringens-associated enteritis. Comparative Immunology, Microbiology and Infectious Diseases, 36(5), 449-464.
29. Uzal, F. A., & Songer, J. G. (2008). Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. Journal of Veterinary Diagnostic Investigation, 20(3), 253-265.
30. Smedley, J. G., Fisher, D. J., Sayeed, S., Chakrabarti, G., & McClane, B. A. (2004). The enteric toxins of Clostridium perfringens. Reviews of Physiology, Biochemistry and Pharmacology, 152, 183-204.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.